Close

Ratings by Raymond James (Dane Leone)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/10/2022 Allogene ALLO Downgrade Market Perform
(Outperform)
15.96
(15.96)
0% Details
8/5/2022 Cytokinetics CYTK Maintain Outperform
(N/A)
 
 
  Details
8/2/2022 Blueprint Medicines BPMC Maintain Strong Buy
(N/A)
 
 
  Details
8/2/2022 bluebird bio BLUE Upgrade Outperform
(Market Perform)
4.05
(6.30)
55.56% Details
6/29/2022 Seagen SGEN New Coverage Outperform
(N/A)
178.47
(169.08)
-5.26% Details
6/3/2022 Bristol-Myers Squibb Co. BMY Downgrade Market Perform
(Outperform)
75.07
(74.52)
-0.73% Details
5/5/2022 Allogene ALLO Maintain Outperform
(N/A)
 
 
  Details
4/26/2022 G1 Therapeutics GTHX Maintain Outperform
(Outperform)
 
 
  Details
4/25/2022 Nkarta Inc. NKTX Maintain Outperform
(N/A)
 
 
  Details
4/4/2022 Curis CRIS Downgrade Market Perform
(Outperform)
2.43
(1.05)
-56.79% Details
3/29/2022 Ayala Pharmaceuticals AYLA Maintain Outperform
(N/A)
 
 
  Details
3/14/2022 BridgeBio Pharma BBIO Maintain Outperform
(Outperform)
 
 
  Details
3/10/2022 Nkarta Inc. NKTX New Coverage Outperform
(N/A)
10.34
(17.22)
66.54% Details
3/10/2022 Nkarta Inc. NKTX New Coverage Outperform
(N/A)
10.34
(10.34)
0% Details
2/14/2022 Regenxbio Inc. RGNX Maintain Strong Buy
(Strong Buy)
 
 
  Details
12/27/2021 BridgeBio Pharma BBIO Maintain Outperform
(N/A)
 
 
  Details
12/22/2021 Compass Therapeutics CMPX New Coverage Outperform
(N/A)
3.01
(3.00)
-0.33% Details
11/24/2021 LianBio LIAN New Coverage Outperform
(N/A)
14.57
(2.58)
-82.29% Details
11/18/2021 Cytokinetics CYTK New Coverage Outperform
(N/A)
39.24
(50.47)
28.62% Details
11/16/2021 Xilio Therapeutics Inc XLO New Coverage Outperform
(N/A)
22.20
(2.40)
-89.19% Details
11/9/2021 Blueprint Medicines BPMC Maintain Strong Buy
(N/A)
 
 
  Details
10/15/2021 Ocular Therapeutix OCUL Maintain Strong Buy
(N/A)
 
 
  Details
10/13/2021 Curis CRIS New Coverage Outperform
(N/A)
7.54
(1.05)
-86.07% Details
10/7/2021 Tarsus Pharmaceuticals TARS Maintain Strong Buy
(N/A)
 
 
  Details
9/23/2021 Allogene ALLO Upgrade Outperform
(Market Perform)
25.67
(15.96)
-37.83% Details
8/24/2021 Regeneron Pharma REGN Maintain Market Perform
(N/A)
 
 
  Details
7/19/2021 Cytokinetics CYTK Maintain Outperform
(N/A)
 
 
  Details
6/29/2021 Tarsus Pharmaceuticals TARS Maintain Strong Buy
(N/A)
 
 
  Details
3/26/2021 Cytokinetics CYTK Maintain Outperform
(N/A)
 
 
  Details
2/24/2021 Xencor, Inc. XNCR Upgrade Outperform
(Market Perform)
48.35
(30.89)
-36.11% Details
2/19/2021 Galapagos NV GLPG Upgrade Outperform
(Market Perform)
83.80
(53.77)
-35.84% Details
2/16/2021 G1 Therapeutics GTHX Maintain Outperform
(N/A)
 
 
  Details
2/11/2021 Regenxbio Inc. RGNX Maintain Strong Buy
(N/A)
 
 
  Details
2/2/2021 Sage Therapeutics SAGE New Coverage Market Perform
(N/A)
80.65
(42.38)
-47.45% Details
1/6/2021 Regenxbio Inc. RGNX Upgrade Strong Buy
(Outperform)
44.91
(31.52)
-29.82% Details
11/30/2020 Sage Therapeutics SAGE Downgrade Market Perform
(Outperform)
75.57
(42.38)
-43.92% Details
11/17/2020 G1 Therapeutics GTHX Downgrade Outperform
(Strong Buy)
13.19
(13.00)
-1.44% Details
11/13/2020 Ocular Therapeutix OCUL Maintain Strong Buy
(N/A)
 
 
  Details
11/12/2020 Adverum Biotechnologies ADVM Upgrade Market Perform
(Underperform)
13.37
(1.41)
-89.45% Details
11/10/2020 Tarsus Pharmaceuticals TARS New Coverage Strong Buy
(N/A)
23.19
(16.46)
-29.02% Details
10/26/2020 Amgen AMGN Upgrade Outperform
(Market Perform)
227.98
(250.62)
9.93% Details
10/16/2020 Blueprint Medicines BPMC Maintain Strong Buy
(N/A)
 
 
  Details
10/16/2020 Simulations Plus SLP New Coverage Outperform
(N/A)
71.90
(62.96)
-12.43% Details
10/8/2020 Cytokinetics CYTK Downgrade Outperform
(Strong Buy)
27.66
(50.47)
82.47% Details
10/8/2020 Amgen AMGN Downgrade Market Perform
(Outperform)
257.67
(250.62)
-2.74% Details
9/22/2020 Bristol-Myers Squibb Co. BMY Maintain Outperform
(N/A)
 
 
  Details
9/21/2020 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
8/10/2020 Sage Therapeutics SAGE Upgrade Outperform
(Market Perform)
50.70
(75.57)
49.05% Details
7/28/2020 Bristol-Myers Squibb Co. BMY New Coverage Outperform
(N/A)
57.85
(74.52)
28.82% Details
7/14/2020 Blueprint Medicines BPMC Maintain Strong Buy
(N/A)
 
 
  Details
7/10/2020 Cytokinetics CYTK New Coverage Strong Buy
(N/A)
26.92
(27.66)
2.75% Details
6/26/2020 Adverum Biotechnologies ADVM Downgrade Underperform
(Market Perform)
23.32
(13.37)
-42.67% Details
6/11/2020 Magenta Therapeutics MGTA Maintain Outperform
(N/A)
 
 
  Details
6/10/2020 Ayala Pharmaceuticals AYLA New Coverage Outperform
(N/A)
15.16
(1.39)
-90.83% Details
6/1/2020 Allogene ALLO Downgrade Market Perform
(Outperform)
46.54
(25.67)
-44.84% Details
4/28/2020 Blueprint Medicines BPMC Maintain Strong Buy
(N/A)
 
 
  Details
3/30/2020 Amgen AMGN Upgrade Outperform
(Market Perform)
198.49
(257.67)
29.82% Details
3/3/2020 Ocular Therapeutix OCUL Upgrade Strong Buy
(Outperform)
4.69
(5.27)
12.37% Details
2/20/2020 bluebird bio BLUE Downgrade Market Perform
(Strong Buy)
88.22
(6.30)
-92.86% Details
2/19/2020 bluebird bio BLUE Downgrade Market Perform
(Strong Buy)
88.22
(6.30)
-92.86% Details
2/10/2020 Ocular Therapeutix OCUL Maintain Outperform
(N/A)
 
 
  Details
1/6/2020 BridgeBio Pharma BBIO Maintain Outperform
(N/A)
 
 
  Details
12/24/2019 Regeneron Pharma REGN New Coverage Market Perform
(N/A)
375.62
(640.95)
70.64% Details
12/24/2019 Amgen AMGN New Coverage Market Perform
(N/A)
243.06
(198.49)
-18.34% Details
11/5/2019 Blueprint Medicines BPMC Upgrade Strong Buy
(Outperform)
67.12
(53.00)
-21.04% Details
9/11/2019 Blueprint Medicines BPMC Upgrade Outperform
(Market Perform)
72.90
(67.12)
-7.93% Details
8/15/2019 Blueprint Medicines BPMC New Coverage Market Perform
(N/A)
85.76
(72.90)
-15% Details
8/7/2019 Xencor, Inc. XNCR Downgrade Market Perform
(Outperform)
46.27
(48.35)
4.5% Details
7/26/2019 BridgeBio Pharma BBIO New Coverage Outperform
(N/A)
28.12
(10.42)
-62.94% Details
7/15/2019 Galapagos NV GLPG Downgrade Market Perform
(Strong Buy)
145.75
(83.80)
-42.5% Details
6/14/2019 BioTime, Inc. BTX New Coverage Market Perform
(N/A)
1.00
(0.56)
-44% Details
6/14/2019 Regenxbio Inc. RGNX New Coverage Outperform
(N/A)
46.85
(31.52)
-32.72% Details
6/14/2019 Adverum Biotechnologies ADVM New Coverage Market Perform
(N/A)
11.06
(23.32)
110.85% Details
5/21/2019 Ocular Therapeutix OCUL Downgrade Outperform
(Strong Buy)
3.37
(4.69)
39.17% Details
3/15/2019 Xencor, Inc. XNCR New Coverage Outperform
(N/A)
29.28
(46.27)
58.03% Details
3/15/2019 Magenta Therapeutics MGTA New Coverage Outperform
(N/A)
14.27
(1.65)
-88.44% Details
3/15/2019 Gritstone Oncology GRTS New Coverage Outperform
(N/A)
10.74
(4.69)
-56.33% Details
3/14/2019 Allogene ALLO New Coverage Outperform
(N/A)
26.89
(46.54)
73.08% Details
3/8/2019 Ocular Therapeutix OCUL Maintain Strong Buy
(N/A)
 
 
  Details
1/7/2019 Loxo Oncology LOXO Downgrade Market Perform
(Strong Buy)
139.87
(234.80)
67.87% Details
12/3/2018 Ocular Therapeutix OCUL Maintain Strong Buy
(N/A)
 
 
  Details
11/15/2018 Ocular Therapeutix OCUL New Coverage Strong Buy
(N/A)
5.29
(3.37)
-36.29% Details
11/15/2018 Loxo Oncology LOXO New Coverage Strong Buy
(N/A)
159.08
(139.87)
-12.08% Details
11/15/2018 Galapagos NV GLPG New Coverage Strong Buy
(N/A)
102.79
(145.75)
41.79% Details